Topic

Treating inflammatory Steady

702 applications whose title mentions it. Its share of new filings over the last two years is -3% below the four years before.

Allowance rate

55%

−20 pts vs the USPTO 585 decided

Months to first action

17.5 mo

−1.1 vs the USPTO

Applications

702.0

in the record

Allowed

323.0

262 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Where it is examined

Domains and art units

CPC subclasses

A61K391 apps

C07K115 apps

A61P72 apps

C07D32 apps

C12N17 apps

G01N17 apps

Art units

164764 apps

162942 apps

OPAP41 apps

164438 apps

164638 apps

162736 apps

Examiners

Who examines it, and how it fares with each

Docket Central43 apps

n/a

Phillip Gambel16 apps

69%

Robert S Landsman12 apps

92%

Jon McClelland Lockard12 apps

36%

Maher M Haddad11 apps

73%

Dong Jiang10 apps

80%

Regina M Deberry8 apps

50%

Ralph J Gitomer8 apps

88%

Bars show the share of decided applications that were allowed.

Unlock the examiners behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who files it

Companies and institutions

BIOGEN MA INC.10 apps

89%

Genentech, Inc.10 apps

78%

NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT9 apps

78%

Boehringer Ingelheim International GmbH7 apps

33%

CHEMOCENTRYX, INC.7 apps

86%

YALE UNIVERSITY7 apps

50%

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents

SUGHRUE MION, PLLC16 apps

75%

FOLEY & LARDNER LLP14 apps

25%

WILSON SONSINI GOODRICH & ROSATI14 apps

42%

HAMILTON, BROOK, SMITH & REYNOLDS, P.C.12 apps

50%

NIXON & VANDERHYE, PC12 apps

58%

AMGEN INC.10 apps

80%

Bars show the share of decided applications that were allowed.

Unlock the firms behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19882675	Methods for Treating TSLP-Associated Inflammatory Diease using Anti-TSLP Antibody	2026-10-06	Pending	0	0	n/a
19881706	NOVEL FEBUXOSTAT DERIVATIVES AND COMPOSITION FOR PREVENTING OR TREATING INFLAMMATOR…	2026-10-02	Pending	0	0	n/a
19881013	FOOD COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY JOINT DISEASES	2026-09-30	Pending	0	0	n/a
15153988	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15280958	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15916349	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15399482	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15991961	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15601755	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15651643	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in